Cargando…

Emergency myelopoiesis contributes to immune cell exhaustion and pulmonary vascular remodelling

BACKGROUND AND PURPOSE: Pulmonary hypertension (PH) secondary to chronic lung disease (World Health Organization Group 3 PH) is deadly, with lung transplant being the only available long‐term treatment option. Myeloid‐derived cells are known to affect progression of both pulmonary fibrosis and PH, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Chunhua, Lu, Yuanqing, Williams, Mason A., Brantly, Mark L., Ventetuolo, Corey E., Morel, Laurence M., Mehrad, Borna, Scott, Edward W., Bryant, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240454/
https://www.ncbi.nlm.nih.gov/pubmed/31793661
http://dx.doi.org/10.1111/bph.14945
_version_ 1783715221694578688
author Fu, Chunhua
Lu, Yuanqing
Williams, Mason A.
Brantly, Mark L.
Ventetuolo, Corey E.
Morel, Laurence M.
Mehrad, Borna
Scott, Edward W.
Bryant, Andrew J.
author_facet Fu, Chunhua
Lu, Yuanqing
Williams, Mason A.
Brantly, Mark L.
Ventetuolo, Corey E.
Morel, Laurence M.
Mehrad, Borna
Scott, Edward W.
Bryant, Andrew J.
author_sort Fu, Chunhua
collection PubMed
description BACKGROUND AND PURPOSE: Pulmonary hypertension (PH) secondary to chronic lung disease (World Health Organization Group 3 PH) is deadly, with lung transplant being the only available long‐term treatment option. Myeloid‐derived cells are known to affect progression of both pulmonary fibrosis and PH, although the mechanism of action is unknown. Therefore, we investigated the effect of myeloid cell proliferation induced by emergency myelopoiesis on development of PH and therapy directed against programmed death‐ligand 1 (PD‐L1), expressed by myeloid cells in prevention of pulmonary vascular remodelling. EXPERIMENTAL APPROACH: LysM.Cre‐DTR (“mDTR”) mice were injected with bleomycin (0.018 U·g(−1), i.p.) while receiving either vehicle or diphtheria toxin (DT; 100 ng, i.p.) to induce severe PH. Approximately 4 weeks after initiation of bleomycin protocol, right ventricular pressure measurements were performed and tissue samples collected for histologic assessment. In a separate experiment, DT‐treated mice were given anti‐PD‐L1 antibody (αPD‐L1; 500 μg, i.p.) preventive treatment before bleomycin administration. KEY RESULTS: Mice undergoing induction of emergency myelopoiesis displayed more severe PH, right ventricular remodelling and pulmonary vascular muscularization compared to controls, without a change in lung fibrosis. This worsening of PH was associated with increased pulmonary myeloid‐derived suppressor cell (MDSC), particularly polymorphonuclear MDSC (PMN‐MDSC). Treatment with αPD‐L1 normalized pulmonary pressures. PD‐L1 expression was likewise found to be elevated on circulating PMN‐MDSC from patients with interstitial lung disease and PH. CONCLUSIONS AND IMPLICATIONS: PD‐L1 is a viable therapeutic target in PH, acting through a signalling axis involving MDSC. LINKED ARTICLES: This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.1/issuetoc
format Online
Article
Text
id pubmed-8240454
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82404542022-01-01 Emergency myelopoiesis contributes to immune cell exhaustion and pulmonary vascular remodelling Fu, Chunhua Lu, Yuanqing Williams, Mason A. Brantly, Mark L. Ventetuolo, Corey E. Morel, Laurence M. Mehrad, Borna Scott, Edward W. Bryant, Andrew J. Br J Pharmacol Pulmonary Hypertension and Right Heart Failure: New Therapeutic Avenue/Approaches ‐ Research Papers BACKGROUND AND PURPOSE: Pulmonary hypertension (PH) secondary to chronic lung disease (World Health Organization Group 3 PH) is deadly, with lung transplant being the only available long‐term treatment option. Myeloid‐derived cells are known to affect progression of both pulmonary fibrosis and PH, although the mechanism of action is unknown. Therefore, we investigated the effect of myeloid cell proliferation induced by emergency myelopoiesis on development of PH and therapy directed against programmed death‐ligand 1 (PD‐L1), expressed by myeloid cells in prevention of pulmonary vascular remodelling. EXPERIMENTAL APPROACH: LysM.Cre‐DTR (“mDTR”) mice were injected with bleomycin (0.018 U·g(−1), i.p.) while receiving either vehicle or diphtheria toxin (DT; 100 ng, i.p.) to induce severe PH. Approximately 4 weeks after initiation of bleomycin protocol, right ventricular pressure measurements were performed and tissue samples collected for histologic assessment. In a separate experiment, DT‐treated mice were given anti‐PD‐L1 antibody (αPD‐L1; 500 μg, i.p.) preventive treatment before bleomycin administration. KEY RESULTS: Mice undergoing induction of emergency myelopoiesis displayed more severe PH, right ventricular remodelling and pulmonary vascular muscularization compared to controls, without a change in lung fibrosis. This worsening of PH was associated with increased pulmonary myeloid‐derived suppressor cell (MDSC), particularly polymorphonuclear MDSC (PMN‐MDSC). Treatment with αPD‐L1 normalized pulmonary pressures. PD‐L1 expression was likewise found to be elevated on circulating PMN‐MDSC from patients with interstitial lung disease and PH. CONCLUSIONS AND IMPLICATIONS: PD‐L1 is a viable therapeutic target in PH, acting through a signalling axis involving MDSC. LINKED ARTICLES: This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.1/issuetoc John Wiley and Sons Inc. 2020-02-04 2021-01 /pmc/articles/PMC8240454/ /pubmed/31793661 http://dx.doi.org/10.1111/bph.14945 Text en © 2019 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Pulmonary Hypertension and Right Heart Failure: New Therapeutic Avenue/Approaches ‐ Research Papers
Fu, Chunhua
Lu, Yuanqing
Williams, Mason A.
Brantly, Mark L.
Ventetuolo, Corey E.
Morel, Laurence M.
Mehrad, Borna
Scott, Edward W.
Bryant, Andrew J.
Emergency myelopoiesis contributes to immune cell exhaustion and pulmonary vascular remodelling
title Emergency myelopoiesis contributes to immune cell exhaustion and pulmonary vascular remodelling
title_full Emergency myelopoiesis contributes to immune cell exhaustion and pulmonary vascular remodelling
title_fullStr Emergency myelopoiesis contributes to immune cell exhaustion and pulmonary vascular remodelling
title_full_unstemmed Emergency myelopoiesis contributes to immune cell exhaustion and pulmonary vascular remodelling
title_short Emergency myelopoiesis contributes to immune cell exhaustion and pulmonary vascular remodelling
title_sort emergency myelopoiesis contributes to immune cell exhaustion and pulmonary vascular remodelling
topic Pulmonary Hypertension and Right Heart Failure: New Therapeutic Avenue/Approaches ‐ Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240454/
https://www.ncbi.nlm.nih.gov/pubmed/31793661
http://dx.doi.org/10.1111/bph.14945
work_keys_str_mv AT fuchunhua emergencymyelopoiesiscontributestoimmunecellexhaustionandpulmonaryvascularremodelling
AT luyuanqing emergencymyelopoiesiscontributestoimmunecellexhaustionandpulmonaryvascularremodelling
AT williamsmasona emergencymyelopoiesiscontributestoimmunecellexhaustionandpulmonaryvascularremodelling
AT brantlymarkl emergencymyelopoiesiscontributestoimmunecellexhaustionandpulmonaryvascularremodelling
AT ventetuolocoreye emergencymyelopoiesiscontributestoimmunecellexhaustionandpulmonaryvascularremodelling
AT morellaurencem emergencymyelopoiesiscontributestoimmunecellexhaustionandpulmonaryvascularremodelling
AT mehradborna emergencymyelopoiesiscontributestoimmunecellexhaustionandpulmonaryvascularremodelling
AT scottedwardw emergencymyelopoiesiscontributestoimmunecellexhaustionandpulmonaryvascularremodelling
AT bryantandrewj emergencymyelopoiesiscontributestoimmunecellexhaustionandpulmonaryvascularremodelling